A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
The CJEU broadens the scope of European SPCs, but shortens validity of its duration in certain Member States
Tekijät: Daniel Acquah
Kustantaja: Oxford University Press
Kustannuspaikka: Oxford
Julkaisuvuosi: 2017
Journal: Journal of Intellectual Property Law and Practice
Lehden akronyymi: JIPLP
Vuosikerta: 12
Numero: 4
Aloitussivu: 263
Lopetussivu: 264
Sivujen määrä: 2
ISSN: 1747-1532
eISSN: 1747-1540
DOI: https://doi.org/10.1093/jiplp/jpx016
Verkko-osoite: https://academic.oup.com/jiplp/article/12/4/263/3065362/The-CJEU-broadens-the-scope-of-European-SPCs-but
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/19260413
The Court of Justice of the European Union (CJEU) has clarified that, where a medicinal product has been the subject of a marketing authorization (MA) within the European Economic Area (EEA), before that granted in a Member State of the European Union (EU), and even before the Member State’s accession to the EU, the EEA MA must be taken into account for the purpose of determining the duration of the supplementary protection certificate granted in the EU.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
